Norris Medicines has informed that, as per company’s Code of Internal Procedures and Conduct for Regulating, Monitoring and Reporting of Trading by Insiders framed pursuant to the Security and Exchange Board of India (Prohibition of Insider Trading) Regulation, 2015, the Trading Window for dealing in the Securities of the Company will be closed for the Financial year ended on declaration of Audited Financial Results of the Company for the Financial year ended on March, 31st 2018 for all the designated persons (Including Promotes and Directors) of the Company from 15th May, 2018 till 48 hours of working days after the announcement of the Audited Financial Result of the Company to the Stock Exchanges i.e. till 29th May, 2018. The Trading Window shall re-open with effect from 30th May, 2018.
The above information is a part of company’s filings submitted to BSE.
